doi:10.3969/j.issn.1673-8640.2019.10.023

Abstract

CLC Number:

R446.1

Figures/Tables 2

References 12

[1]	崔步云. 关注中国布鲁杆菌病疫情发展和疫苗研究[J]. 中国地方病学杂志,2012,31(4):355-356.
[2]	胡剑飞,崔步云,关平原,等. 布鲁氏菌外膜蛋白的研究进展[J]. 疾病监测,2010,25(5):380-389.
[3]	钟志军,于爽,徐杰,等. 布鲁菌进化和分类学研究进展[J]. 中国兽医学报,2011,31(8):1228-1235.
[4]	高彦辉,赵丽军,孙殿军,等. 布鲁氏菌病防治基础研究现状与展望[J]. 中国科学:生命科学,2014,44(6):628-635.
[5]	张芳毓,钱爱东. 布鲁氏菌诊断学研究进展[J]. 吉林畜牧兽医,2011,32( 1):10-14.
[6]	SALI M,DE MAIO F,TARANTINO M,et al.Rapid and safe one-step extraction method for the identification of Brucella strains at genus and species level by MALDI-TOF mass spectrometry[J]. PLoS One,2018,13(6):e0197864.
[7]	张改文,史新涛,郝卫芳,等. 布鲁氏菌病三种诊断方法的比较[J]. 中国动物检疫,2013,30( 10):38-40.
[8]	PEERIDOGAHEH H,GOLMOHAMMADI M G,POURFARZI F.Evaluation of ELISA and Brucellacapt tests for diagnosis of human brucellosis[J]. Iran J Microbiol,2013,5( 1) :14-18.
[9]	周梅. 布鲁杆菌实验室诊断技术研究进展[J]. 职业与健康,2012,28( 23):2971-2973.
[10]	HUBER B,SCHOLZ H C,LUCERO N,et al.Development of a PCR assay for tying and subtyping of Brucella species[J]. Int J Med Microbiol,2009,299(8):563-573.
[11]	HEKMATIMOGHADDAM S,SADEH M,KHALILI M B,et al.Comparison of PCR,Wright agglutination test and blood culture for diagnosis of brucellosis in suspected patients[J]. Pak J Biol Sci,2013,16(22):1589-1592.
[12]	木合塔尔·艾山,邰新平,李全,等. 2009年新疆人间布鲁氏杆菌病疫情分析[J]. 疾病预防控制通报,2011,26(1):54-55.

[1]	FAN Lieying. Research status and application prospects of biomarkers for membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1111-1114.
[2]	SUN Lincheng, LI Jianfeng, CHENG Weili, JI Panyun. Roles of anti-PLA2R IgG4 antibody and PLA2R IgG4/IgG ratio in primary membranous nephropathy [J]. Laboratory Medicine, 2023, 38(12): 1115-1120.
[3]	LIU Qingyang, YUAN Jianming, XIA Jinjun, JIANG Fengying, WANG Qiubo, WANG Xiaoming. CXCL9 as a potential diagnostic marker of rheumatoid arthritis based on GEO database and experimental verification [J]. Laboratory Medicine, 2023, 38(12): 1121-1129.
[4]	YANG Xiao, LI Enling, WU Lixia, DAI Yingxin, WANG Zhiqing, HUANG Hao, ZHENG Bing. Influence of cytoplasmic antinuclear antibody on indirect immunofluorescence assay based antineutrophil cytoplasmic antibody determination [J]. Laboratory Medicine, 2023, 38(12): 1135-1140.
[5]	XIANG Jin, LIU Aiping, HU Yao, WU Zhiyuan, CAO Guojun, GUAN Ming. ANA profiles in COVID-19 patients and influence of serum heat-inactivation on ANA determination [J]. Laboratory Medicine, 2023, 38(12): 1141-1146.
[6]	CHENG Yu, XU Zhen, LU Liu, DING Menglei, YU Shanshan, ZONG Ming, FAN Lieying. Expression and risk factors of anti-ACE-2 antibody in serum of patients with COVID-19 [J]. Laboratory Medicine, 2023, 38(12): 1147-1152.
[7]	. [J]. Laboratory Medicine, 2023, 38(12): 1153-1156.
[8]	. [J]. Laboratory Medicine, 2023, 38(12): 1157-1159.
[9]	WANG Hongling, LIU Mengna, BAI Ping, LIAO Huanjin. Risk factors of relapse following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia [J]. Laboratory Medicine, 2023, 38(12): 1160-1166.
[10]	YANG Xilan, WANG Jinyu, LIU Shuyu, ZHAN Yiyang, LIU Jing, JIA Jian. Correlation between hyperlipidemia and endothelial microparticles in elderly patients from Gulou Community in Nanjing [J]. Laboratory Medicine, 2023, 38(12): 1167-1172.
[11]	DAI Fangfang, LU Xinxin, YU Yanhua, CHEN Ming, SUN Guizhen. Analysis of Mycobacterium infection in HIV/AIDS patients [J]. Laboratory Medicine, 2023, 38(12): 1173-1176.
[12]	GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182.
[13]	. [J]. Laboratory Medicine, 2023, 38(12): 1183-1185.
[14]	. [J]. Laboratory Medicine, 2023, 38(12): 1186-1190.
[15]	. [J]. Laboratory Medicine, 2023, 38(12): 1191-1194.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 2

References 12

Related Articles 15

Recommended Articles

Metrics